55 /100
HIGH RISK
Score updated Jul 14, 2026

BIII — Black Spade Acquisition III Co Dilution Risk Tracker

Track BIII dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BIII — Get alerts when the score changes →

As of July 14, 2026, Black Spade Acquisition III Co (BIII) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Black Spade Acquisition III Co has a market capitalization of $229.08M, 17.25M shares outstanding, 17 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BIII.
🔔 Track BIII — Get forecast alerts →

💹 Market Data

Market Cap$229.08M
Shares Outstanding17.25M
Float17.25M
CashN/A
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

17 institutional holders · 3.78M shares
#1 SONA ASSET MANAGEMENT (US) LLC 600.0K shares
#2 MILLENNIUM MANAGEMENT LLC 600.0K shares
#3 Wealthspring Capital LLC 558.9K shares
+ 14 more holders Sign up free to view →

📉 Short Interest

Short Interest1.1K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

8-K 8K EVENT Jan 26, 2026
8-K/A 8K EVENT Jan 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BIII Shareholders

Black Spade Acquisition III Co (BIII) has a DilutionScore of 55/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch's EDGAR monitoring for BIII shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BIII in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for BIII alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BIII Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BIII — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BIII
📊 BIII FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BIII Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.